Evidence map›Paper›PMID 35758822›Full record

ArticleBioinformatics (Oxford, England)2022

Semi-deconvolution of bulk and single-cell RNA-seq data with application to metastatic progression in breast cancer.

Haoyun Lei, Xiaoyan A Guo, Yifeng Tao, Kai Ding, Xuecong Fu, Steffi Oesterreich, Adrian V Lee, Russell Schwartz

Open access · hybridAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Haoyun LeiComputational Biology Department, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Xiaoyan A GuoComputational Biology Department, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Yifeng TaoComputational Biology Department, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Kai DingDepartment of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, Magee-Womens Research Institute, Pittsburgh, PA 15213, USA.
Xuecong FuDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Steffi OesterreichDepartment of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, Magee-Womens Research Institute, Pittsburgh, PA 15213, USA.
Adrian V LeeDepartment of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, Magee-Womens Research Institute, Pittsburgh, PA 15213, USA.
Russell SchwartzComputational Biology Department, Carnegie Mellon University, Pittsburgh, PA 15213, USA.ORCID 0000-0002-4970-2252
Carnegie Mellon University · USMagee-Womens Research Institute · US

Funding

Reconstructing mechanisms of somatic variation in diverse cellular lineagesR01HG010589 · NHGRI · CARNEGIE-MELLON UNIVERSITY · PI SCHWARTZ, RUSSELL S · 2020 to 2023
$1.4M
DECONVOLUTION OF CLONAL HETEROGENEITY FROM BULK AND SINGLE-CELL VARIATION DATAR21CA216452 · NCI · CARNEGIE-MELLON UNIVERSITY · PI SCHWARTZ, RUSSELL S · 2017 to 2018
$342k
NCI NIH HHS R21 CA216452NHGRI NIH HHS R01 HG010589NIH HHS R21CA216452
6 · The paper itself

Abstract

motivationIdentifying cell types and their abundances and how these evolve during tumor progression is critical to understanding the mechanisms of metastasis and identifying predictors of metastatic potential that can guide the development of new diagnostics or therapeutics. Single-cell RNA sequencing (scRNA-seq) has been especially promising in resolving heterogeneity of expression programs at the single-cell level, but is not always feasible, e.g. for large cohort studies or longitudinal analysis of archived samples. In such cases, clonal subpopulations may still be inferred via genomic deconvolution, but deconvolution methods have limited ability to resolve fine clonal structure and may require reference cell type profiles that are missing or imprecise. Prior methods can eliminate the need for reference profiles but show unstable performance when few bulk samples are available.

resultsIn this work, we develop a new method using reference scRNA-seq to interpret sample collections for which only bulk RNA-seq is available for some samples, e.g. clonally resolving archived primary tissues using scRNA-seq from metastases. By integrating such information in a Quadratic Programming framework, our method can recover more accurate cell types and corresponding cell type abundances in bulk samples. Application to a breast tumor bone metastases dataset confirms the power of scRNA-seq data to improve cell type inference and quantification in same-patient bulk samples. AVAILABILITY AND IMPLEMENTATION: Source code is available on Github at https://github.com/CMUSchwartzLab/RADs.

Indexed as

Breast NeoplasmsSingle-Cell AnalysisFemaleGene Expression ProfilingHumansRNA-SeqSequence Analysis, RNA

Identifiers

PMID35758822
PMCPMC9235482
OpenAlexW4226141498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.